Bluejay Diagnostics Inc. (NASDAQ: BJDX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BLUEJAY DIAGNOSTICS INC.

Bluejay Diagnostics Inc. (NASDAQ: BJDX)
Listen to this Section


$4.82
-0.0700 ( -1.43% ) 41.5K

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Market Data


Open $4.82
Previous Close $4.89
Volume 41.5K
Market Cap $5.06M
Day Range $4.69 - $4.90
52 Week Range $1.62 - $16.68
Shares Outstanding 1.03M
Change % -1.43%
Net Change ▼ -0.0700
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2021
CountryUnited States
UnderwriterDawson James, I-Bankers Securities, ViewTrade, more

Insider Ownership Transactions

Total Amount Purchased: 1,000.00

Date Type Amount Purchased Purchaser
2023-12-14 Buy 500.00 Dey Indranil
2023-12-14 Buy 500.00 Dey Svetlana

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 71 Nov 07, 2025
s-3 Registration statements 17 Oct 23, 2025
schedule Other 2 Oct 16, 2025
8-k 8K-related 20 Oct 14, 2025
8-k 8K-related 54 Oct 09, 2025
8-k 8K-related 13 Aug 15, 2025
8-k 8K-related 15 Aug 11, 2025
10-q Quarterly Reports 63 Aug 07, 2025
8-k 8K-related 14 Jul 28, 2025
8-k 8K-related 12 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy